Apart from diabetes, the GLP-1R is also an auspicious structural target for the detection of insulinomas (Christ et al. 2009) and congenital hyperinsulinism (CHI) (Boss et al. 2022), which are both conditions of hyper-insulin production resulting in hypoglycaemia. The gene discussed is INS; the disease is congenital isolated hyperinsulinism.